These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 17344906

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Targeted gene silencing into solid tumors with electrically mediated siRNA delivery.
    Golzio M, Mazzolini L, Paganin-Gioanni A, Teissié J.
    Methods Mol Biol; 2009; 555():15-27. PubMed ID: 19495685
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A.
    J Biotechnol; 2006 Jun 25; 124(1):12-25. PubMed ID: 16413079
    [Abstract] [Full Text] [Related]

  • 7. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM, Bennett J, Tolentino MJ.
    Mol Vis; 2003 May 30; 9():210-6. PubMed ID: 12789138
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
    Santel A, Aleku M, Keil O, Endruschat J, Esche V, Durieux B, Löffler K, Fechtner M, Röhl T, Fisch G, Dames S, Arnold W, Giese K, Klippel A, Kaufmann J.
    Gene Ther; 2006 Sep 30; 13(18):1360-70. PubMed ID: 16625242
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA.
    Inoue T, Sugimoto M, Sakurai T, Saito R, Futaki N, Hashimoto Y, Honma Y, Arai I, Nakaike S.
    J Gene Med; 2007 Nov 30; 9(11):994-1001. PubMed ID: 17703497
    [Abstract] [Full Text] [Related]

  • 15. Targeted lipoplexes for siRNA delivery.
    Cardoso A, Trabulo S, Moreira JN, Düzgüneş N, de Lima MC.
    Methods Enzymol; 2009 Nov 30; 465():267-87. PubMed ID: 19913172
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A.
    Curr Opin Mol Ther; 2007 Aug 30; 9(4):345-52. PubMed ID: 17694447
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Small interfering RNA (siRNA) delivery into monocyte-derived dendritic cells by electroporation.
    Prechtel AT, Turza NM, Theodoridis AA, Kummer M, Steinkasserer A.
    J Immunol Methods; 2006 Apr 20; 311(1-2):139-52. PubMed ID: 16556448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.